Cargando…

Promising Epigenetic Biomarkers Associated With Cancer-Associated-Fibroblasts for Progression of Kidney Renal Clear Cell Carcinoma

Kidney renal clear cell carcinoma (KIRC) is the most common malignant kidney tumor as its characterization of highly metastatic potential. Patients with KIRC are associated with poor clinical outcomes with limited treatment options. Up to date, the underlying molecular mechanisms of KIRC pathogenesi...

Descripción completa

Detalles Bibliográficos
Autores principales:	You, Yongke, Ren, Yeping, Liu, Jikui, Qu, Jianhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495159/ https://www.ncbi.nlm.nih.gov/pubmed/34630525 http://dx.doi.org/10.3389/fgene.2021.736156

Ejemplares similares

Calreticulin as a prognostic biomarker and correlated with immune infiltrate in kidney renal clear cell carcinoma
por: Sun, Ming, et al.
Publicado: (2022)

Antioxidant Gene Signature Impacts the Immune Infiltration and Predicts the Prognosis of Kidney Renal Clear Cell Carcinoma
por: Ren, Xueting, et al.
Publicado: (2021)

Gene Signature Associated With Bromodomain Genes Predicts the Prognosis of Kidney Renal Clear Cell Carcinoma
por: Lu, Junwan, et al.
Publicado: (2021)

The Construction and Analysis of ceRNA Network and Immune Infiltration in Kidney Renal Clear Cell Carcinoma
por: Deng, Lugang, et al.
Publicado: (2021)

C1QC is a prognostic biomarker with immune-related value in kidney renal clear cell carcinoma
por: Yao, Wentao, et al.
Publicado: (2023)

Sarcomatoid-associated gene risk index for clear cell renal cell carcinoma
por: Zuo, You, et al.
Publicado: (2022)

Identification of a Five-miRNA Signature for Diagnosis of Kidney Renal Clear Cell Carcinoma
por: Zhao, Enyang, et al.
Publicado: (2022)

Development and validation of a novel necroptosis-related score to improve the outcomes of clear cell renal cell carcinoma
por: Chen, Ji, et al.
Publicado: (2022)

The Epigenetics of Renal Cell Tumors: from Biology to Biomarkers
por: Henrique, Rui, et al.
Publicado: (2012)

Identification of MX2 as a Novel Prognostic Biomarker for Sunitinib Resistance in Clear Cell Renal Cell Carcinoma
por: Wei, Yuang, et al.
Publicado: (2021)

Identification and Quantification of Necroptosis Landscape on Therapy and Prognosis in Kidney Renal Clear Cell Carcinoma
por: Xin, Sheng, et al.
Publicado: (2022)

Identification of RNA Transcript Makers Associated With Prognosis of Kidney Renal Clear Cell Carcinoma by a Competing Endogenous RNA Network Analysis
por: Yang, Qiwei, et al.
Publicado: (2020)

EMILIN2 is associated with prognosis and immunotherapy in clear cell renal cell carcinoma
por: Zhao, Guangjian, et al.
Publicado: (2022)

The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma
por: Zhang, Lishuo, et al.
Publicado: (2023)

Cuproptosis-related gene FDX1 as a prognostic biomarker for kidney renal clear cell carcinoma correlates with immune checkpoints and immune cell infiltration
por: Yao, Yimin, et al.
Publicado: (2023)

An inflammation-related signature could predict the prognosis of patients with kidney renal clear cell carcinoma
por: Yu, Qingxin, et al.
Publicado: (2022)

Molecular subtypes based on cuproptosis regulators and immune infiltration in kidney renal clear cell carcinoma
por: Liu, Aibin, et al.
Publicado: (2022)

Circular RNA Foxo3: A Promising Cancer-Associated Biomarker
por: Yang, Tianli, et al.
Publicado: (2021)

Identification of a Metastasis-Associated Gene Signature of Clear Cell Renal Cell Carcinoma
por: Gao, Suhua, et al.
Publicado: (2021)

Identification of Immune-Related Subtypes and Characterization of Tumor Microenvironment Infiltration in Kidney Renal Clear Cell Carcinoma
por: Qin, Huisheng, et al.
Publicado: (2022)

N7-Methylguanosine-Related lncRNAs: Integrated Analysis Associated With Prognosis and Progression in Clear Cell Renal Cell Carcinoma
por: Ming, Jie, et al.
Publicado: (2022)

Acyl-CoA Thioesterase 8 and 11 as Novel Biomarkers for Clear Cell Renal Cell Carcinoma
por: Xu, Chao-Liang, et al.
Publicado: (2020)

NCKAP1 is a Prognostic Biomarker for Inhibition of Cell Growth in Clear Cell Renal Cell Carcinoma
por: Chen, Jiasheng, et al.
Publicado: (2022)

Identification of a Novel Epigenetic Signature CHFR as a Potential Prognostic Gene Involved in Metastatic Clear Cell Renal Cell Carcinoma
por: Chen, Xiangling, et al.
Publicado: (2021)

Epigenetic modifications in esophageal cancer: An evolving biomarker
por: Liu, Wen-Jian, et al.
Publicado: (2023)

Epigenetic Markers Are Associated With Differences in Isocyanate Biomarker Levels in Exposed Spray-Painters
por: Taylor, Laura W., et al.
Publicado: (2021)

A Fatty Acid Metabolism Signature Associated With Clinical Therapy in Clear Cell Renal Cell Carcinoma
por: Wei, Zhihao, et al.
Publicado: (2022)

Whole-Exome Sequencing Identifies Somatic Mutations Associated With Mortality in Metastatic Clear Cell Kidney Carcinoma
por: Mendoza-Alvarez, Alejandro, et al.
Publicado: (2019)

Whole-genome sequencing revealed novel prognostic biomarkers and promising targets for therapy of ovarian clear cell carcinoma
por: Itamochi, Hiroaki, et al.
Publicado: (2017)

Development and Validation of Nine-RNA Binding Protein Signature Predicting Overall Survival for Kidney Renal Clear Cell Carcinoma
por: Zhong, Weimin, et al.
Publicado: (2020)

Generation and Analysis of Pyroptosis-Based and Immune-Based Signatures for Kidney Renal Clear Cell Carcinoma Patients, and Cell Experiment
por: Lin, Gaoteng, et al.
Publicado: (2022)

Establishment of a prognostic ferroptosis- and immune-related long noncoding RNAs profile in kidney renal clear cell carcinoma
por: Han, Zhijun, et al.
Publicado: (2022)

Epigenetic Biomarkers in Cardiovascular Diseases
por: Soler-Botija, Carolina, et al.
Publicado: (2019)

CRC-EBD: Epigenetic Biomarker Database for Colorectal Cancer
por: Liu, Xingyun, et al.
Publicado: (2020)

Construction and verification of a novel prognostic risk model for kidney renal clear cell carcinoma based on immunity-related genes
por: Liu, Yufeng, et al.
Publicado: (2023)

AURKB: a promising biomarker in clear cell renal cell carcinoma
por: Wan, Bangbei, et al.
Publicado: (2019)

Systematic Construction and Validation of a Novel Macrophage Differentiation–Associated Prognostic Model for Clear Cell Renal Cell Carcinoma
por: Liu, Chen, et al.
Publicado: (2022)

Prognostic and Diagnostic Values of Semaphorin 5B and Its Correlation With Tumor-Infiltrating Immune Cells in Kidney Renal Clear-Cell Carcinoma
por: Ding, Junping, et al.
Publicado: (2022)

miR-21-5p/PRKCE axis implicated in immune infiltration and poor prognosis of kidney renal clear cell carcinoma
por: Wang, Jinxiang, et al.
Publicado: (2022)

Genomic Instability Promotes the Progression of Clear Cell Renal Cell Carcinoma Through Influencing the Immune Microenvironment
por: Wei, Xiyi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sh3rdmi2jj2qtq26uojhfh86b0